Tivanisiran sodium ophthalmic solution ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
53シェーグレン症候群1

53. シェーグレン症候群


臨床試験数 : 305 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04819269
(ClinicalTrials.gov)
May 25, 202124/3/2021Tivanisiran for Dry Eye in Subjects With Sjögren's SyndromeTivanisiran for Dry Eye in Subjects With Sjögren's SyndromeDry Eye Disease;Sjögren SyndromeDrug: Tivanisiran sodium ophthalmic solution;Drug: Vehicle ophthalmic solutionSylentis, S.A.NULLRecruiting18 YearsN/AAll200Phase 3United States;Spain